These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 566382)

  • 21. Experimental in vivo cross-resistance of vinca alkaloid drugs.
    Maral R; Bourut C; Chenu E; Mathe G
    Cancer Chemother Pharmacol; 1981; 5(3):197-9. PubMed ID: 7296754
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Chemistry and mode of action of vinca alkaloids].
    Wilms K
    Planta Med; 1972 Nov; 22(3):324-33. PubMed ID: 4649588
    [No Abstract]   [Full Text] [Related]  

  • 23. The in vitro and in vivo effects of vinca alkaloids on the noradrenergic innervation of the vas deferens.
    Gardiner SM; Tomlinson DR; Bennett T
    Med Biol; 1976 Jun; 54(3):193-202. PubMed ID: 945856
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Vindesine: a new vinca alkaloid.
    Bayssas M; Gouveia J; de Vassal F; Misset JL; Schwarzenberg L; Ribaud P; Musset M; Jasmin C; Hayat M; Mathé G
    Recent Results Cancer Res; 1980; 74():91-7. PubMed ID: 7003662
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Pharmacology of Catharanthus alkaloids].
    Levêque D; Wihlm J; Jehl F
    Bull Cancer; 1996 Mar; 83(3):176-86. PubMed ID: 8695919
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Thrombocytopenias. Therapy of idiopathic thrombopenic purpura (ITP)].
    Cacciola E; Musso R; Russo M
    Haematologica; 1979 Oct; 64 Suppl():160-75. PubMed ID: 120275
    [No Abstract]   [Full Text] [Related]  

  • 27. Action of the vinca alkaloids vincristine, vinblastine, and desacetyl vinblastine amide on microtubules in vitro.
    Himes RH; Kersey RN; Heller-Bettinger I; Samson FE
    Cancer Res; 1976 Oct; 36(10):3798-802. PubMed ID: 954003
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The use of vinca alkaloids in preparation for splenectomy of corticosteroid refractory chronic immune thrombocytopenic purpura patients.
    Szczepanik AB; Sikorska A; Slomkowski M; Konopka L
    Int J Lab Hematol; 2007 Oct; 29(5):347-51. PubMed ID: 17824915
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Effect and role of vinca-alkaloids in the treatment of metastatic breast cancers].
    Herrera A; Delgado FM; Besenval M; Merle S; Badri N; Marty M; Krikorian A
    Pathol Biol (Paris); 1990 Oct; 38(8):860-1. PubMed ID: 2274391
    [No Abstract]   [Full Text] [Related]  

  • 30. [Results of F-Leurosin therapy].
    Farkas E; Eckhardt S
    Orv Hetil; 1977 Jun; 118(24):1403-7. PubMed ID: 865824
    [No Abstract]   [Full Text] [Related]  

  • 31. [Transfusion of platelets loaded with periwinkle alkaloids as a treatment for chronic idiopathic thrombocytopenic purpura (author's transl)].
    Wautier JL; Boizard B; Caen JP
    Nouv Presse Med; 1979 Jan; 8(3):185-8. PubMed ID: 576021
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Therapy of a refractory idiopathic thrombocytopenic purpura by vinblastine-loaded thrombocytes (author's transl)].
    Budde U; Schmidt R; Gerloff J; Etzel F
    Blut; 1979 Feb; 38(2):139-41. PubMed ID: 570071
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Collateral sensitivity of a methotrexate-resistant L1210 cell line to the vinca alkaloids.
    Poppitt DG; McGown AT; Fox BW
    Cancer Chemother Pharmacol; 1984; 13(1):43-6. PubMed ID: 6733841
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Effects of colchicine and vinca alkaloids on human platelets. 3. Influence on primary internal contraction and secondary aggregation.
    White JG
    Am J Pathol; 1969 Mar; 54(3):467-78. PubMed ID: 5774266
    [No Abstract]   [Full Text] [Related]  

  • 35. Inhibition of tubulin-microtubule polymerization by drugs of the Vinca alkaloid class.
    Owellen RJ; Hartke CA; Dickerson RM; Hains FO
    Cancer Res; 1976 Apr; 36(4):1499-502. PubMed ID: 1260766
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Platelets loaded with vinblastine or vincristine in idiopathic thrombocytopenic purpura. Prognostic factors].
    Ambriz Fernández R; Escobedo de la Peña J; Avilés Miranda A; Morales Polanco M; Chávez Sánchez G; Chávez Vela J; Guillén Mariscal C; Pizzuto Chávez J
    Rev Invest Clin; 1983; 35(3):213-9. PubMed ID: 6685339
    [No Abstract]   [Full Text] [Related]  

  • 37. The effect of vinca alkaloids in enhancing the sensitivity of a methotrexate-resistant (L1210/R7A) line, studied by flow cytometric and chromosome number analysis.
    McGown AT; Poppitt DG; Swindell R; Fox BW
    Cancer Chemother Pharmacol; 1984; 13(1):47-53. PubMed ID: 6733842
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [New antitumor derivatives of vinblastine].
    Bölcskei H; Szántay C; Mák M; Balázs M; Szántay C
    Acta Pharm Hung; 1998 Mar; 68(2):87-93. PubMed ID: 9592933
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Clinical applications of Vinca alkaloids.
    Rosenthal RC
    J Am Vet Med Assoc; 1981 Dec; 179(11):1084, 1086. PubMed ID: 6948802
    [No Abstract]   [Full Text] [Related]  

  • 40. The action of two Vinca alkaloids on B16 melanoma in vitro.
    Donoso JA; Himes RH
    Cancer Biochem Biophys; 1984 Jun; 7(2):133-45. PubMed ID: 6467174
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.